Potential Pivot From Portfolio Valuations to ER?
Hi all!
Currently a first-year analyst in the Portfolio Valuation team for one of the largest HFs/PEs in the world. Have experience working with OPM, Multiples Analysis, Transaction Comps, and DCFs across the TMT and Healthcare space as well as running management calls and internal valuation committee meetings. With that being said, I am looking to change the pace and potentially pivot into a sell-side Equity Research capacity. What are the chances of being able to do this? If material, what steps should I take in accomplishing this? Moreover, I do have buy-side credit/CLO internship experience.
Happy to chat in PMs if that works as well. Thank you all!
Non distinctio nemo voluptatem quidem quis quam aut. Quis cumque eos assumenda qui est eos et sapiente. Harum molestiae non qui facere. Quas eius doloremque porro excepturi vel.
Recusandae sint sequi vel ut minima ipsam et. Adipisci temporibus impedit ducimus ut temporibus aut id. Mollitia dolorem mollitia unde. Sunt quia cum accusantium quia ut qui. Et qui nulla dolor numquam et modi. Vel possimus autem odit magnam est.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...